Note: The transactions reported here refer to legal insider trading — purchases, sales, and other dealings in company securities by executives, directors, and major shareholders, which are required by law to be disclosed to the SEC via Form 4 filings within two business days of the transaction. This article covers the top 100 most significant transactions by dollar value from today's filings. This is entirely distinct from illegal insider trading, which involves buying or selling securities based on material, non-public information in violation of US federal securities law and equivalent legislation in other jurisdictions.
Today’s insider trading activity leaned heavily bearish, with sales outpacing purchases by a wide margin. Out of 100 total trades, only 10 were buys, while 90 were sales, signaling a cautious or profit-taking stance among corporate insiders. The most notable transactions involved substantial sales by major shareholders and directors, overshadowing a handful of significant buys in the financial and electric vehicle sectors.
The largest insider purchases were concentrated in two companies. Gogoro Inc. (GGR) saw Director Yin Chung-Yao make two separate buys totaling $70.2 million, demonstrating strong confidence in the electric vehicle company. Banco Bradesco S.A. (BBD) also recorded significant insider activity, with Director Denise Aguiar Alvarez purchasing $33.6 million in shares and Director Rubens Aguiar Alvarez executing two buys worth a combined $64 million. These substantial investments suggest optimism about the long-term prospects of both firms.
On the sell side, Eli Lilly and Company (LLY) dominated with two proposed sales by shareholder Lilly Endowment, Inc., each valued at $347.2 million. Medline Inc. (MDLN) followed, with GIC Private Ltd, a 10% owner, offloading $274.8 million in shares. Elastic N.V. (ESTC) also saw notable sales, including a proposed $191 million transaction by director CMXI B.V. and a $135.2 million sale by director Steven Schuurman. These large-scale disposals could reflect portfolio rebalancing or profit-taking after recent market gains.
Related Reading
Regulatory Developments→Market News→Bulls & Bears Outlook→Today’s data highlights a clear divergence in sentiment, with insiders in select sectors doubling down on their investments while others lock in gains. The overwhelming volume of sales may hint at broader market caution, particularly in healthcare and tech. Investors should monitor whether this trend continues in the coming sessions. Track all insider trades in real time on the MarketsFN Insider Trading Tracker.
Top 10 Stocks — Insider Activity
Price Charts — Top 3 Stocks
LLY — Eli Lilly and Company
LLY — Eli Lilly and Company
MDLN — Medline Inc.
MarketsFN Insider Trading Tracker
Monitor all SEC Form 4 filings in real time — filter by company, role, transaction type and dollar value.
Source: SEC Form 4 filings. Updated twice daily.
